Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
de Mendoza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, Menéndez-Arias L, Dalmau D, Soriano V.
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.
AIDS REVIEWS . 11(1): 39-51. Nº de citas: 17
-
González-Nieto D, Gómez-Hernández JM, Larrosa B, Gutiérrez C, Muñoz MD, Fasciani I, O'Brien J, Zappalà A, Cicirata F, Barrio LC.
Regulation of neuronal connexin-36 channels by pH
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 105(44): 17169-17174. Nº de citas: 61
-
Hernández-Novoa B, Antela A, Gutiérrez C, Pérez-Molina JA, Pérez-Elías MJ, Dronda F, Moreno A, Casado JL, Page C, Pumares M, Galán JC, Moreno S.
Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study.
HIV MEDICINE . 9(4): 187-191. Nº de citas: 5
-
Pérez-Elías MJ, Moreno A, Moreno S, López D, Antela A, Casado JL, Dronda F, Gutiérrez C, Quereda C, Navas E, Abraira V, Rodríguez MA.
Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.
HIV CLINICAL TRIALS . 6(6): 312-319. Nº de citas: 10
-
Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V.
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
JOURNAL OF MEDICAL VIROLOGY . 77(1): 23-28. Nº de citas: 19
-
Pérez-Elías MJ, Moreno S, Gutiérrez C, López D, Abraira V, Moreno A, Dronda F, Casado JL, Antela A, Rodríguez MA.
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir.
AIDS . 19(7): 695-698. Nº de citas: 21
-
Domínguez-Berjón MF, Pichiule-Castañeda M, García-Riolobos MC, Esteban-Vasallo MD, Arenas-González SM, Morán-Arribas M, Verdejo-Ortés J, Zoni AC, Álvarez-Castillo MC, Astray J, others members of the ESTVIH group.
A feasibility study for 3 strategies promoting HIV testing in primary health care in Madrid, Spain (ESTVIH project).
JOURNAL OF EVALUATION IN CLINICAL PRACTICE . : .
-
Casado JL, Santiuste C, Vivancos MJ, Monsalvo M, Moreno A, Perez-Elías MJ, Del Rey JM, Moreno S.
Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
HIV MEDICINE . : .
-
Vizcarra P, Fontecha M, Monsalvo M, Vivancos MJ, Rojo A, Casado JL.
Efficacy and safety of dolutegravir plus boosted-darunavir dual therapy among highly treatment-experienced patients.
ANTIVIRAL THERAPY . : .
-
Pérez-Nadales E, Gutiérrez-Gutiérrez B, Natera AM, Abdala E, Reina Magalhães M, Mularoni A, Monaco F, Pierrotti LC, Freire MP, Iyer RN, Metha S, Calvi EG, Tumbarello M, Falcone M, Fernández-Ruiz M, Costa-Mateo JM, Rana MM, Strabelli TMV, Paul M, Fariñas MC, Clemente WT, Roilides E, Muñoz García P, Dewispelaere L, Loeches B, Lowman W, Tan BH, Escudero-Sánchez R, Bodro Marimont M, Grossi PA, Soldani F, Gunseren F, Nestorova N, Pascual Á, Martínez-Martínez L, Aguado JM, Rodríguez-Baño J, Torre-Cisneros J, INCREMENT-SOT Investigators.
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia.
AMERICAN JOURNAL OF TRANSPLANTATION . : .
-
Ros-Castelló V, Quereda C, López-Sendón J, Corral I.
Post-hypoxic myoclonus after COVID-19 infection recovery.
Movement Disorders Clinical Practice . 7(8): 983-984.
-
Pierrotti LC, Pérez-Nadales E, Fernández-Ruiz M, Gutiérrez-Gutiérrez B, Hock Tan B, Carratalà J, Oriol I, Paul M, Cohen-Sinai N, López-Medrano F, San-Juan R, Montejo M, Freire MP, Cordero E, David MD, Merino E, Mehta Steinke S, Grossi PA, Cano Á, Seminari EM, Valerio M, Gunseren F, Rana M, Mularoni A, Martín-Dávila P, van Delden C, Hamiyet Demirkaya M, Koçak Tufan Z, Loeches B, Iyer RN, Soldani F, Eriksson BM, Pilmis B, Rizzi M, Coussement J, Clemente WT, Roilides E, Pascual Á, Martínez-Martínez L, Rodríguez-Baño J, Torre-Cisneros J, María Aguado J, Investigators from the REIPI/INCREMENT-SOT Group.
Efficacy of ß-lactam/ß-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
TRANSPLANT INFECTIOUS DISEASE . : .
-
Nunez-Torron, Claudia, Ferrer-Gomez, Ana, Moreno Moreno, Esther, Perez-Mies, Belen, Villarrubia, Jesus, Chamorro, Sandra, Lopez-Jimenez, Javier, Palacios, J, Piris-Villaespesa, Miguel, Garcia-Cosio, Monica.
Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore
JOURNAL OF CLINICAL PATHOLOGY . : . Nº de citas: 4
-
Rava M, Bisbal O, Domínguez-Domínguez L, Aleman MR, Rivero M, Antela A, Estrada V, Ribera E, Muñoz A, Iribarren JA, Moreno S, Rubio R, Jarrín I.
Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
AIDS . : .
-
Albasanz-Puig A, Gudiol C, Puerta-Alcalde P, Ayaz CM, Machado M, Herrera F, Martín-Dávila P, Laporte-Amargós J, Cardozo C, Akova M, Álvarez-Uría A, Torres D, Fortún J, García-Vidal C, Muñoz P, Bergas A, Pomares H, Mercadal S, Durà-Miralles X, García-Lerma E, Pallarès N, Carratalà J.
Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for Gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study).
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . : .
-
Braojos F, Fuentes I, Saugar JM, Martín O, López-Vélez R, Norman FF.
Amebic abscess and sexual contact.
JOURNAL OF TRAVEL MEDICINE . : .
-
Gutiérrez-Gutiérrez B, Pérez-Nadales E, Pérez-Galera S, Fernández-Ruiz M, Carratalà J, Oriol I, Cordero E, Lepe JA, Tan BH, Corbella L, Paul M, Natera AM, David MD, Montejo M, Iyer RN, Camera Pierrotti L, Merino E, Steinke SM, Rana MM, Muñoz P, Mularoni A, van Delden C, Grossi PA, Seminari EM, Gunseren F, Lease ED, Roilides E, Fortún J, Arslan H, Coussement J, Tufan ZK, Pilmis B, Rizzi M, Loeches B, Eriksson BM, Abdala E, Soldani F, Lowman W, Trindade Clemente W, Bodro M, Fariñas MC, Kazak E, Martínez-Martínez L, Aguado JM, Torre-Cisneros J, Pascual Á, Rodríguez-Baño J, Investigators from the REIPI/ESGICH/ESGBIS/INCREMENT-SOT Group.
Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing Enterobacterales in kidney transplant recipients: a propensity score and DOOR-based analysis.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . : .
-
Casado JL, Vizcarra P, Vivancos MJ, Martinez-Sanz J, Perez-Elías MJ, Moreno A, Vallejo A.
Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19.
Infection . : 1-5.